APVO - Aptevo Therapeutics EPS beats by $0.03 misses on revenue November, 12 2021 08:30 AM Aptevo Therapeutics Inc. Aptevo Therapeutics (NASDAQ:APVO): Q3 GAAP EPS of -$1.45 beats by $0.03. Revenue of $3.1M (+112.3% Y/Y) misses by $0.55M. Press Release For further details see: Aptevo Therapeutics EPS beats by $0.03, misses on revenue